osimertinib,tepotinib
astrazeneca,merck
['osimertinib', 'nsclc', 'sclc', 'tepotinib']
 : adding tepotinib to osimertinib is safe and highly active in egfr mutant nsclc with acquired met amplification. met fish is useful and met tki alone is not enough #esmo22 
Medical Oncologist @KantonsspitalLU | Associate Professor @unibern | member @sakk_ch @etop_eu @myESMO @IASLC